Literature DB >> 9925153

Blood flow rate: an important determinant of urea clearance and delivered Kt/V.

R A Ward1.   

Abstract

Implementation of the Dialysis Outcomes Quality Initiative (DOQI) Guidelines for hemodialysis adequacy will necessitate an increase in delivered Kt/V for many patients. Before increasing Kt/V by prolonging the patient's treatment time, it is important to verify that the prescribed dialyzer urea clearance is being achieved. The principal determinant of dialyzer urea clearance is blood flow rate. Actual blood flow rates are frequently less than the nominal blood flow rate displayed by the dialysis machine, particularly at higher flow rates, leading to lower than expected urea clearances. The major reason for the reduction in blood flow rate is a low pressure in the arterial blood line proximal to the blood pump. This effect can be mitigated by the use of large bore access needles. For quality assurance purposes, actual blood flow rates should be determined by correcting nominal blood flow rates for pressure effects using empirical relationships or by using an ultrasonic flow meter. Because a poorly functioning blood access may further reduce the effective blood flow rate, blood access performance should also be monitored regularly.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925153     DOI: 10.1016/s1073-4449(99)70011-7

Source DB:  PubMed          Journal:  Adv Ren Replace Ther        ISSN: 1073-4449


  2 in total

1.  Assessment of hemodialysis adequacy in patients with chronic kidney disease in the hemodialysis unit at Tanta University Hospital in Egypt.

Authors:  M El-Sheikh; G El-Ghazaly
Journal:  Indian J Nephrol       Date:  2016 Nov-Dec

2.  Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients.

Authors:  Masateru Yamamoto; Tomio Matsumoto; Hiromitsu Ohmori; Masahiko Takemoto; Masanobu Ikeda; Ryo Sumimoto; Tsuyoshi Kobayashi; Akihiko Kato; Hideki Ohdan
Journal:  BMC Nephrol       Date:  2021-06-15       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.